Meeting Previews
-
Schedule Highlights from the Program Chairs: Monday, April 28
Don’t miss the Innovative Technologies Plenary Session, Presidential Select Symposium, and more, say Program Committee Chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD.
-
Fourth Plenary Session will examine cancer from ecosystem perspective
Tuesday’s plenary presentations will explore how new insights into dynamic relationships are opening the door to novel therapeutic strategies aimed at disrupting cancer’s supportive environment.
-
Meet-the-Expert Sessions feature talks from prominent leaders in cancer research
Four distinguished experts in cancer immunology, small cell lung cancer, multigene sequencing, and molecular epidemiology will present during unique sessions Monday evening.
-
Sessions highlight advances in cancer early detection and interception
A series of three scientific sessions will explore the early detection of cancer and the interception of new tumors, progressive disease, and recurrent lesions.
-
Schedule Highlights from the Program Chairs: Sunday, April 27
Don’t miss the Opening Ceremony and Opening Plenary, the first sessions of the highly anticipated clinical trials plenary program, and more, say Program Committee Chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD.
-
AACR Presidential Address and Presidential Select Symposium will take a global view on cancer
AACR President Patricia M. LoRusso, DO, PhD (hc), FAACR, will address efforts to accelerate research and advance personalized medicine around the world.
-
Opening Plenary to feature presentations from leading researchers on cutting-edge topics
Today’s Plenary Session will expand on this year’s meeting theme, revolving around the concept of carrying scientific discoveries through to impactful therapeutics.
-
Clinical trials sessions to spotlight groundbreaking clinical research
Exciting clinical trials will be presented across four Clinical Trials Plenary Sessions and three Clinical Trials Minisymposia, each highlighting advances in a specific subject area.
-
Third Plenary Session to focus on the role of technological advances
Monday’s plenary platform will present four technologies helping to chart new horizons in oncology by advancing our understanding of cancer and developing better therapies for patients.
-
New Drugs on the Horizon sessions hint at therapeutic frontiers ahead
This three-part series will delve into behind-the-scenes strategies in oncology drug design and development, offering expert insight into the next-generation landscape.